Sage Therapeutics, Inc. earnings per share and revenue

SAGE earnings per share for the last quarter are -1.53 USD whereas the estimation was -1.55 USD which accounts for 1.59% surprise. Company revenue for the same period amounts to 11.87 M USD despite the estimated figure of 10.80 M USD. Estimated earnings per share for the next quarter are -1.48 USD, and revenue is expected to reach 14.40 M USD. Also watch annual changes over time to get a bigger picture of SAGE earnings per share and revenue dynamics.